|
Boston Scientific Shows Upbeat Data
Daily Markets Leading medical devices player Boston Scientific (NYSE:BSX) presented positive data from the Research in Severe Asthma (RISA) trial at a conference in Amsterdam. It was observed that patients with severe refractory asthma, when treated with Alair … Boston Scientific begins enrolment for nerve stimulation trial |
View full post on asthma – Google News